Concourse Financial Group Securities’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,216
| Closed | -$57.4K | – | 5510 |
|
|
2024
Q4 | $57.4K | Buy |
5,216
+2,169
| +71% | +$23.9K | ﹤0.01% | 1155 |
|
|
2024
Q3 | $62.6K | Buy |
3,047
+521
| +21% | +$10.7K | ﹤0.01% | 1103 |
|
|
2024
Q2 | $56.5K | Buy |
2,526
+1,185
| +88% | +$26.5K | ﹤0.01% | 1127 |
|
|
2024
Q1 | $36.9K | Buy |
1,341
+737
| +122% | +$20.3K | ﹤0.01% | 1306 |
|
|
2023
Q4 | $18.4K | Buy |
+604
| New | +$18.4K | ﹤0.01% | 1511 |
|
|
2023
Q3 | – | Sell |
-45
| Closed | -$1.84K | – | 6174 |
|
|
2023
Q2 | $1.84K | Hold |
45
| – | – | ﹤0.01% | 2032 |
|
|
2023
Q1 | $1.68K | Hold |
45
| – | – | ﹤0.01% | 2085 |
|
|
2022
Q4 | $1.57K | Hold |
45
| – | – | ﹤0.01% | 2079 |
|
|
2022
Q3 | $3K | Hold |
45
| – | – | ﹤0.01% | 1757 |
|
|
2022
Q2 | $2K | Hold |
45
| – | – | ﹤0.01% | 2035 |
|
|
2022
Q1 | $3K | Hold |
45
| – | – | ﹤0.01% | 1966 |
|
|
2021
Q4 | $5K | Hold |
45
| – | – | ﹤0.01% | 2046 |
|
|
2021
Q3 | $6K | Buy |
+45
| New | +$6K | ﹤0.01% | 2033 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5179 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5031 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4901 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4704 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4575 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4561 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4498 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4294 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4477 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4417 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4293 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4017 |
|